44.20000 EUR
1.2
2.79%
Last update Dec 15, 4:30 PM CET
Main market
Day range
44.20000
47.40000
Previous close
43
Open
46
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
44.20
1.20
2.79%

Statistics

Valuation metrics
Market cap
899.10M
Enterprise value
657.56M
Trailing P/E (ttm)
-5.56
Forward P/E
PEG ratio
0.18
Price/Sales (ttm)
14.36
Price/Book (mrq)
11.98
Enterprise Value/Revenue
12.33
Enterprise Value/EBITDA
-5.71
Overview
Shares outstanding
19.65M
Float
18.91M
Shares short
% Held by insiders
0.66%
% Held by institutions
71.14%
Average volume (10 days)
890
Average volume (90 days)
441
Price summary
52-Week low
6.46
52-Week high
57
52-Week change
71.02 1,099.1%
Beta
1.28
50-Day moving average
50.00
200-Day moving average
26.30
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
-192.87%
Operating margin
-267.45%
Operational effectiveness
Return on assets
-27.98%
Return on equity
-180.24%
Income statement
Revenue (ttm)
53.35M
Revenue per share (ttm)
4.10
Quarterly revenue growth (yoy)
-51.10%
Gross profit (ttm)
46.55M
EBITDA
-115.22M
Net income to common (ttm)
-102.90M
Diluted EPS (ttm)
-8.37
Quarterly earnings growth (yoy)
-51.82%
Balance sheet
Total cash (mrq)
230.28M
Total cash per share (mrq)
13.28
Total debt (mrq)
142.39M
Total Debt/Equity (mrq)
196.37
Current ratio (mrq)
424.10%
Book value per share (mrq)
3.69
Cash flow
Cash flow statement
-161.71M
Levered free cash flow (LFCF)
-48.67M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 27 minutes

14:32
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).